- Home
- / Ono Pharmaceutical
Ono Pharmaceutical
Stock Price
¥2 K
2024-10-29
Market Capitalization
¥910.2 B
2024-10-29
Revenue
¥515.8 B
FY, 2026
Ono Pharmaceutical Summary
Company Summary
- Overview
- Ono Pharmaceutical (小野薬品工業株式会社) is a company that produces, purchases, and sells pharmaceuticals and diagnostic reagents. It provides injection and oral drugs for the treatment of type 1 and 2 diabetes, chronic heart failure, overactive bladder, secondary hyperparathyroidism, joint function improvement, etc.
- Type
- Public
- Status
- Active
- Founded
- 1717
- HQ
- Osaka, JP | view all locations
- Website
- https://www.ono-pharma.com
- Cybersecurity rating
Table of Contents
Key People
Satoshi Numata, Executive Director, Digital & IT Strategy
Hiroshi Ichikawa, Senior Director, Medical External Affairs
Hiromu Habashita, Deputy Executive Director, Discovery & Research
Operating MetricsView all
New Product Launches
31
10.7%
FY, 2022
Clinical Trials
82
5.1%
FY, 2022
Research Projects
200
FY, 2022
LocationsView all
18 locations detected
Osaka, Osaka HQ
Japan
8-2, Kyutaromachi 1-chome, Chuo-ku
Cambridge, MA
United States
Riverfront Office Park, 1 Main Street, Suite 1050
Fujinomiya, Shizuoka
Japan
5221-1,Azahigashishimogumi,Kitayama
Fukuoka, Fukuoka
Japan
12-2 Narayamachi, Hakata Ward
Hiroshima, Hiroshima
Japan
11-6, Hikari-machi 2-chome, Higashi-ku
Kyoto, Kyoto
Japan
35 Bishamonchō, Shimogyo Ward
Ono Pharmaceutical Financials
Summary Financials
- Revenue (FY, 2026)
- ¥515.8B
- Gross profit (FY, 2026)
- ¥412.7B
- Net income (FY, 2026)
- ¥69.9B
- Cash (FY, 2026)
- ¥237.0B
- EBIT (FY, 2026)
- ¥92.2B
- Enterprise value
- $794.1B